Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

Status Terminated

Clinical Trial Summary

This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer

Clinical Trial Description

The objective of the study is to use 18F sodium fluoride (fluorine F-18 sodium fluoride) PET/CT scanning to detect and characterize lesions in patients who have suspected skeletal malignancy. We hypothesize that scanning with 18F-NaF (fluorine F-18 sodium fluoride) is more sensitive for skeletal abnormalities and may better characterize lesions than conventional imaging. ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Bone Cancer

Clinical Trial Details

NCT number	NCT01541358
Study type	Interventional
Source	Stanford University
Contact
Status	Terminated
Phase	N/A
Start date	May 2012
Completion date	September 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03905174` - Massive Implants the Next Generation	N/A
Completed	`NCT00160719` - HLA Sensitization Following Major Cortical Allograft Bone Procedures	Phase 4
Completed	`NCT04974008` - Osteosarcoma Maintenance Therapy With OST31-164	Phase 2
Not yet recruiting	`NCT06070259` - Insights Into Participating in Studies for Bone Cancer
Completed	`NCT01553539` - Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery	Phase 2
Recruiting	`NCT03160274` - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Active, not recruiting	`NCT02880319` - Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone	Phase 2
Completed	`NCT01135849` - B-Receptor Signaling in Cardiomyopathy	N/A
Terminated	`NCT00960063` - A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)	Phase 1
Terminated	`NCT02443103` - Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis	N/A
Recruiting	`NCT04028479` - The Registry of Oncology Outcomes Associated With Testing and Treatment
Terminated	`NCT03525392` - Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.	Phase 1
Terminated	`NCT01313884` - Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma	Phase 2
Completed	`NCT01091883` - Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma	N/A
Terminated	`NCT00127387` - Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia	Phase 2/Phase 3
Not yet recruiting	`NCT03106675` - MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases	N/A
Recruiting	`NCT05830084` - Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma	Phase 1
Completed	`NCT01085565` - Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System	Phase 2
Recruiting	`NCT04307914` - Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases	N/A
Terminated	`NCT01163539` - Cyberknife Radiosurgery and Quality of Life	N/A